TranscripTx, Inc.
3Patents
3Active
3Granted
57Portfolio score
Filing activity: Jul 28, 2020 → Oct 20, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11510997B2 | Treatment of primary ciliary dyskinesia with synthetic messenger RNA | Chemistry; Metallurgy | 4 | Active |
| US11786610B2 | Treatment of primary ciliary dyskinesia with synthetic messenger RNA | Chemistry; Metallurgy | 2 | Active |
| US11642421B2 | Treatment of primary ciliary dyskinesia with synthetic messenger RNA | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.